Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-30T03:32:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Publication notes were added clarifying that publications may relate to the study results and are automatically filled from PubMed. The page revision was updated to v3.3.1.
    Difference
    0.3%
    Check dated 2025-11-23T00:50:23.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The study location list now includes Tainan, Taiwan, 70457 instead of Tainan City, Taiwan, 70457, and the funding-status notice was removed.
    Difference
    0.1%
    Check dated 2025-11-15T17:10:17.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    No significant changes detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-01T08:10:26.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added Cali, Valle del Cauca Department, Colombia, 760042 to the locations list and removed Santiago de Cali, Valle del Cauca Department, Colombia, 760042.
    Difference
    0.0%
    Check dated 2025-10-25T06:39:37.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Update the page to v3.2.0 with a government funding notice about potential delays and current operating status for the NIH Clinical Center; remove the old v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-03T08:56:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.